ArticleAlzheimer disease and associated disorders
Validity of the Montreal Cognitive Assessment-Basic (MoCA-B) in a Dutch Memory Clinic.
Article in Alzheimer disease and associated disorders. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
People with low educational levels or low literacy skills tend to obtain lower scores on cognitive screens, even in the absence of cognitive impairments, possibly resulting in false positive diagnoses. The Montreal Cognitive Assessment-Basic (MoCA-B) has been developed to overcome this, but studies so far are limited to low-income countries. This study examined the MoCA-B [total score and Memory Index Score (MIS)] in a European memory clinic context. Fifty-five controls, 37 patients with mild cognitive impairment and 47 dementia patients were included. Results showed that a MoCA-B total cutoff score <25 is valid for distinguishing controls from MCI or dementia patients. The MoCA-B MIS showed an acceptable diagnostic accuracy for controls versus MCI (<12) and controls versus dementia (<11). No valid cutoff score could be established for MCI versus dementia patients. Our findings show that the MoCA-B can also be validly applied in a European memory clinic setting.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.